Regulation of T:B cell interactions by the Inducible Costimulator molecule: Does ICOS "induce" disease?

Clinical Immunology

Volumn 121, Issue 1, 2006, Pages 13-18

  Shilling, Rebecca A ^a   Bandukwala, Hozefa S ^a   Sperling, Anne I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Allergy; Asthma; Autoimmunity; B cells; Follicular T helper Cells; Humoral immunity; ICOS; Polymorphisms; T cells

Indexed keywords

CD28 ANTIGEN; CD40 LIGAND; INDUCIBLE COSTIMULATOR MOLECULE; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELIAC DISEASE; CELL INTERACTION; CELLULAR IMMUNITY; CHROMOSOME 2Q; COMMON VARIABLE IMMUNODEFICIENCY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; HUMORAL IMMUNITY; HYPERSENSITIVITY REACTION; LYMPHOCYTE ACTIVATION; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL COMMUNICATION; HUMANS; HYPERSENSITIVITY; T-LYMPHOCYTES;

EID: 33748627960     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.04.574     Document Type: Short Survey

References (55)

1. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., and Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397 (1999) 263-266
2. Swallow M.M., Wallin J.J., and Sha W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFa. Immunity 11 (1999) 423-432
3. Brodie D., Collins A.V., Iaboni A., Fennelly J.A., Sparks L.M., Xu X.N., van der Merwe P.A., and Davis S.J. LICOS, a primordial costimulatory ligand?. Curr. Biol. 10 (2000) 333-336
4. Ling V., Wu P.W., Finnerty H.F., Bean K.M., Spaulding V., Fouser L.A., Leonard J.P., Hunter S.E., Zollner R., Thomas J.L., Miyashiro J.S., Jacobs K.A., and Collins M. Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164 (2000) 1653-1657
5. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T., Tafuri-Bladt A., Brankow D., Campbell P., Chang D., Chiu L., Dai T., Duncan G., Elliott G.S., Hui A., McCabe S.M., Scully S., Shahinian A., Shaklee C.L., Van G., Mak T.W., et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402 (1999) 827-832
6. Mages H.W., Hutloff A., Heuck C., Buchner K., Himmelbauer H., Oliveri F., and Kroczek R.A. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur. J. Immunol. 30 (2000) 1040-1047
7. Aicher A., Hayden-Ledbetter M., Brady W.A., Pezzutto A., Richter G., Magaletti D., Buckwalter S., Ledbetter J.A., and Clark E.A. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164 (2000) 4689-4696
8. Dong C., Juedes A.E., Temann U., Shresta S., Allison J.P., Ruddle Richard N.H., and Flavell A. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409 (2001) 97-101
9. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., Freeman G.J., and Sharpe A.H. ICOS is critical for CD40-mediated antibody class switching. Nature 409 (2001) 102
10. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., Boucher L.-M., Bouchard D., Chan V.S.F., Duncan G., Odermatt B., Ho A., Itie A., Horan T., Whoriskey J.S., Pawson T., Penninger J.M., Ohashi P.S., and Mak T.W. ICOS is essential for effective T-helper-cell responses. Nature 409 (2001) 105
11. Mak T.W., Shahinian A., Yoshinaga S.K., Wakeham A., Boucher L.M., Pintilie M., Duncan G., Gajewska B.U., Gronski M., Eriksson U., Odermatt B., Ho A., Bouchard D., Whorisky J.S., Jordana M., Ohashi P.S., Pawson T., Bladt F., and Tafuri A. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4 (2003) 765-772
12. Nurieva R.I., Mai X.M., Forbush K., Bevan M.J., and Dong C. B7h is required for T cell activation, differentiation, and effector function. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14163-14168
13. Nurieva R.I., Duong J., Kishikawa H., Dianzani U., Rojo J.M., Ho I., Flavell R.A., and Dong C. Transcriptional regulation of th2 differentiation by inducible costimulator. Immunity 18 (2003) 801-811
14. Daniels S.E., Bhattacharrya S., James A., Leaves N.I., Young A., Hill M.R., Faux J.A., Ryan G.F., le Souef P.N., Lathrop G.M., Musk A.W., and Cookson W.O. A genome-wide search for quantitative trait loci underlying asthma. Nature 383 (1996) 247-250
15. Bonetti A., Reunanen K., Finnila S., Koivisto K., Wikstrom J., Sumelahti M.L., Pirttila T., Elovaara I., Reunanen M., Saarela J., Peltonen L., Rantamaki T., and Tienari P.J. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun. 5 (2004) 142-146
16. Cantor R.M., Yuan J., Napier S., Kono N., Grossman J.M., Hahn B.H., and Tsao B.P. Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum. 50 (2004) 3203-3210
17. Hoffjan S., and Ober C. Present status on the genetic studies of asthma. Curr. Opin. Immunol. 14 (2002) 709-717
18. Shilling R.A., Pinto J.M., Decker D.C., Schneider D.H., Bandukwala H.S., Schneider J.R., Camoretti-Mercado B., Ober C., and Sperling A.I. Cutting edge: polymorphisms in the ICOS promoter region are associated with allergic sensitization and th2 cytokine production. J. Immunol. 175 (2005) 2061-2065
19. Haimila K., Smedberg T., Mustalahti K., Maki M., Partanen J., and Holopainen P. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun. 5 (2004) 85-92
20. van Heel D.A., Hunt K., Greco L., and Wijmenga C. Genetics in coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19 (2005) 323-339
21. Sollid L.M., and Jabri B. Is celiac disease an autoimmune disorder?. Curr. Opin. Immunol. 17 (2005) 595-600
22. Brophy K., Ryan A.W., Thornton J.M., Abuzakouk M., Fitzgerald A.P., McLoughlin R.M., O'Morain C., Kennedy N.P., Stevens F.M., Feighery C., Kelleher D., and McManus R. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Genes Immun. 7 (2006) 19-26
23. Wicker L.S., Chamberlain G., Hunter K., Rainbow D., Howlett S., Tiffen P., Clark J., Gonzalez-Munoz A., Cumiskey A.M., Rosa R.L., Howson J.M., Smink L.J., Kingsnorth A., Lyons P.A., Gregory S., Rogers J., Todd J.A., and Peterson L.B. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J. Immunol. 173 (2004) 164-173
24. Greve B., Vijayakrishnan L., Kubal A., Sobel R.A., Peterson L.B., Wicker L.S., and Kuchroo V.K. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 157-163
25. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., Eibel H., Fischer B., Schaffer A.A., Mages H.W., Kroczek R.A., and Peter H.H. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4 (2003) 261-268
26. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., Urschel S., Belohradsky B.H., Litzman J., Holm A., Franco J.L., Plebani A., Hammarstrom L., Skrabl A., Schwinger W., and Grimbacher B. ICOS deficiency in patients with common variable immunodeficiency. Clin. Immunol. 113 (2004) 234-240
27. Warnatz K., Bossaller L., Salzer U., Skrabl-Baumgartner A., Schwinger W., van der Burg M., van Dongen J.J., Orlowska-Volk M., Knoth R., Durandy A., Draeger R., Schlesier M., Peter H.H., and Grimbacher B. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107 (2006) 3045-3052
28. Okamoto T., Saito S., Yamanaka H., Tomatsu T., Kamatani N., Ogiuchi H., Uchiyama T., and Yagi J. Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis. J. Rheumatol. 30 (2003) 1157-1163
29. Hutloff A., Buchner K., Reiter K., Baelde H.J., Odendahl M., Jacobi A., Dorner T., and Kroczek R.A. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 3211-3220
30. Lohning M., Hutloff A., Kallinich T., Mages H.W., Bonhagen K., Radbruch A., Hamelmann E., and Kroczek R.A. Expression of ICOS in vivo defines CD4(+) effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197 (2003) 181-193
31. Vinuesa C.G., Cook M.C., Angelucci C., Athanasopoulos V., Rui L., Hill K.M., Yu D., Domaschenz H., Whittle B., Lambe T., Roberts I.S., Copley R.R., Bell J.I., Cornall R.J., and Goodnow C.C. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435 (2005) 452-458
32. Nurieva R.I., Treuting P., Duong J., Flavell R.A., and Dong C. Inducible costimulator is essential for collagen-induced arthritis. J. Clin. Invest. 111 (2003) 701-706
33. Scott B.G., Yang H., Tuzun E., Dong C., Flavell R.A., and Christadoss P. ICOS is essential for the development of experimental autoimmune myasthenia gravis. J. Neuroimmunol. 153 (2004) 16-25
34. Zheng Y., Jost M., Gaughan J.P., Class R., Coyle A.J., and Monestier M. ICOS-B7 homologous protein interactions are necessary for mercury-induced autoimmunity. J. Immunol. 174 (2005) 3117-3121
35. Iwai H., Abe M., Hirose S., Tsushima F., Tezuka K., Akiba H., Yagita H., Okumura K., Kohsaka H., Miyasaka N., and Azuma M. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J. Immunol. 171 (2003) 2848-2854
36. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., Nguyen T., Burwell T., Schneider H., Gonzalo J.A., Gosselin M., Owen L.R., Rudd C.E., and Gutierrez-Ramos J.C. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13 (2000) 95-105
37. Tesciuba A.G., Subudhi S., Rother R.P., Faas S.J., Frantz A.M., Elliot D., Weinstock J., Matis L.A., Bluestone J.A., and Sperling A.I. Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease. J. Immunol. 167 (2001) 1996-2003
38. Rottman J.B., Smith T., Tonra J.R., Ganley K., Bloom T., Silva R., Pierce B., Gutierrez-Ramos J.C., Ozkaynak E., and Coyle A.J. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2 (2001) 605-6011
39. Salomon B., and Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19 (2001) 225-252
40. Ferguson S.E., Han S., Kelsoe G., and Thompson C.B. CD28 is required for germinal center formation. J. Immunol. 156 (1996) 4576-4581
41. Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T., and Kikutani H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1 (1994) 167-178
42. Korthauer U., Graf D., Mages H.W., Briere F., Padayachee M., Malcolm S., Ugazio A.G., Notarangelo L.D., Levinsky R.J., and Kroczek R.A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 539-541
43. Kroczek R.A., Graf D., Brugnoni D., Giliani S., Korthuer U., Ugazio A., Senger G., Mages H.W., Villa A., and Notarangelo L.D. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)". Immunol. Rev. 138 (1994) 39-59
44. Xu J., Foy T.M., Laman J.D., Elliott E.A., Dunn J.J., Waldschmidt T.J., Elsemore J., Noelle R.J., and Flavell R.A. Mice deficient for the CD40 ligand. Immunity 1 (1994) 423-431
45. McAdam A.J., Chang T.T., Lumelsky A.E., Greenfield E.A., Boussiotis V.A., Duke-Cohan J.S., Chernova T., Malenkovich N., Jabs C., Kuchroo V.K., Ling V., Collins M., Sharpe A.H., and Freeman G.J. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4(+) T cells. J. Immunol. 165 (2000) 5035-5040
46. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
47. Spellberg B., and Edwards Jr. J.E. Type 1/Type 2 immunity in infectious diseases. Clin. Infect. Dis. 32 (2001) 76-102
48. Dong C., Temann U.A., and Flavell R.A. Cutting edge: critical role of inducible costimulator in germinal center reactions. J. Immunol. 166 (2001) 3659-3662
49. Rousset G.E., Defrance F., Peronne T., Vezzio C., Hsu N., Kastelein D.H., Moore R., and Banchereau K.W. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1890-1893
50. + T cells. J. Clin. Invest. 115 (2005) 1049-1059
51. Breitfeld D., Ohl L., Kremmer E., Ellwart J., Sallusto F., Lipp M., and Forster R. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192 (2000) 1545-1552
52. Schaerli P., Willimann K., Lang A.B., Lipp M., Loetscher P., and Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192 (2000) 1553-1562
53. + Th cells produce distinct cytokines in different mucosal immune responses. Eur. J. Immunol. 33 (2003) 392-401
54. + T cells. Eur. J. Immunol. 34 (2004) 3562-3571
55. Liang L., Porter E.M., and Sha W.C. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J. Exp. Med. 196 (2002) 97-108